Swiss Stocks Fall on Tariffs, Push for Drug Price Cuts (Correct)

Aug. 4, 2025, 1:36 PM UTC

Swiss stocks dropped as the market reopened after a holiday, on worries about the impact from US President Donald Trump’s punitive 39% export tariff and a push for drugmakers to lower prices.

The Swiss Market Index fell as much as 1.9% Monday, although it pared declines to 0.88% as of 10:15 a.m. in Zurich on optimism that the levies will ultimately be a tool to drive trade negotiations. The benchmark is now up about 1% for 2025.

Drugmakers Novartis AG and Roche Holding AG,which account for almost 30% of the index, dropped 0.7% and 1.4%, respectively. UBS ...



Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.